Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kobold Capital is an Australian investment firm focused on life sciences and emerging medical technologies. The firm seeks to identify high-value opportunities in both public and private life sciences companies. They have a portfolio of four companies and engage in investments across various stages, including pre-seed and pre-IPO.
Kobold Capital invests in life sciences, greentech, deep tech, and artificial intelligence. The firm targets investments that show potential for exponential growth or are approaching significant value inflection points. Their approach includes both private and public investments, emphasizing high-impact opportunities.
Notable companies in Kobold Capital's portfolio include Avexa Ltd (ASX:AVX), Opyl Ltd (ASX:OPL), Admedus Ltd (ASX:AHZ), and CANN Group (ASX:CAN).
Submit your pitch through their website contact form for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.